Trial
NCT01103180
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Temple University; Northwestern University; University of Southern Mississippi
Condition
Borderline Personality Disorder
Intervention
Escitalopram
Why stopped
Funding withdrawn due to inability to accrue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-14